Cargando…
Update on the Development of Anti-Viral Agents Against Hepatitis C
Hepatitis C virus (HCV) infects nearly 170 million people worldwide and causes chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The search for a drug regimen that maximizes efficacy and minimizes side effects is quickly evolving. This review will discuss a wide range of drug targets curre...
Autores principales: | Macarthur, Kristin L., Smolic, Robert, Smolic, Martina V., Wu, Catherine H., Wu, George Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521270/ https://www.ncbi.nlm.nih.gov/pubmed/26357602 http://dx.doi.org/10.14218/JCTH.2013.007XX |
Ejemplares similares
-
An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents
por: Rupcic Rubin, Vinka, et al.
Publicado: (2021) -
Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update
por: Bojanic, Kristina, et al.
Publicado: (2023) -
Mechanisms of Hepatic Cholestatic Drug Injury
por: Kolarić, Tea Omanović, et al.
Publicado: (2019) -
MicroRNAs: Small Molecules with Significant Functions, Particularly in the Context of Viral Hepatitis B and C Infection
por: Megahed, Fayed, et al.
Publicado: (2023) -
Therapeutic Perspectives of IL1 Family Members in Liver Diseases: An Update
por: Ćurčić, Ines Bilić, et al.
Publicado: (2022)